Atlas Trials

The Observation on the Efficacy of Dual Therapy Based on Vonoprazan in Eradicating Helicobacter Pylori

Clinical trial NCT06004401 · UNKNOWN

Trial details

NCT number
NCT06004401
Sponsor
Shanghai Changzheng Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
The Eradication Rate of Helicobacter Pylori
Start date
2023-08-20
Primary completion
2025-08-31
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.